2021 annual financial data

Intellia Therapeutics 2021 Operating margin

Intellia Therapeutics 2021 operating margin with verified reported values.

Direct answer

Operating margin was -810.37%.

Operating income was -267,850,000 USD and net income was -259,718,000 USD.
Operating cash flow was -225,030,000 USD.

Verified data

Revenue
33,053,000 USD
Operating income
-267,850,000 USD
Net income
-259,718,000 USD
Operating cash flow
-225,030,000 USD